{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:49Z","timestamp":1791235369630,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015699","name":"Fresenius Medical Care North America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015699","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Compared with high-flux hemodialysis, postdilution high volume hemodiafiltration was associated with a lower number of hospital admissions.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Compared with high-flux hemodialysis, postdilution high volume hemodiafiltration was associated with reduced days spent in the hospital.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with ESKD undergoing hemodialysis experience high rates of hospitalizations and mortality, partly due to the incomplete removal of some toxic uremic molecules. To improve outcomes, multiple modalities of kidney replacement therapy have been developed, including high-flux hemodialysis and on-line hemodiafiltration (HDF). Notably, on-line high-volume HDF (HV-HDF) has demonstrated mortality benefits over high-flux hemodialysis in some randomized trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study evaluated hospitalization outcomes among in-center dialysis patients treated with HV-HDF and high-flux hemodialysis at Fresenius Medical Care NephroCare centers across Europe, the Middle East, and Africa between January 2019 and December 2022. Data were extracted from the European Clinical Database. The primary outcome was all-cause hospitalization; secondary outcomes included cause-specific hospitalizations. Negative binomial regression was used to estimate incidence rate ratios (IRRs) for hospital outcomes, incorporating inverse probability of treatment weighting to adjust for baseline differences between treatment groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 71,669 patients were included, with 45% receiving hemodialysis and 55% receiving HDF. During the follow-up period, patients in the HDF group underwent a total of 12,741,453 HDF treatments, with a mean convection volume of 25.8 L (84% with CV\u226523L). Compared with hemodialysis, treatment with HDF was associated with a lower incidence of both hospital admissions (adjusted IRR, 0.80; 95% confidence interval, 0.79 to 0.82) and days spent in the hospital (adjusted IRR, 0.80; 95% confidence interval, 0.78 to 0.82). These reductions were consistent across subgroups analyzed and across most major causes of hospitalization, including cardiovascular disease, infections, and fluid-related complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large, real-world cohort spanning multiple regions and dialysis centers, HV-HDF was associated with significantly lower rates of both hospital admissions and days spent in the hospital compared with treatment with high-flux hemodialysis. These findings suggest that HV-HDF may have the potential to reduce morbidity in patients with ESKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000955","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:00:44Z","timestamp":1766509244000},"page":"852-859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9913-6490","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"first","affiliation":[{"name":"Renal Research Institute, New York, New York"},{"name":"Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Winter","sequence":"additional","affiliation":[{"name":"Renal Research Institute, New York, New York"},{"name":"Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-0028","authenticated-orcid":false,"given":"Linda H.","family":"Ficociello","sequence":"additional","affiliation":[{"name":"Renal Research Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n Alejos","family":"Ferrera","sequence":"additional","affiliation":[{"name":"Renal Research Institute, New York, New York"},{"name":"Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9363-6986","authenticated-orcid":false,"given":"Paola","family":"Carioni","sequence":"additional","affiliation":[{"name":"Renal Research Institute, New York, New York"},{"name":"Fresenius Medical Care, Global Medical Office, Palazzo Pignano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Apel","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Arkossy","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-4544","authenticated-orcid":false,"given":"Michael","family":"Anger","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care Holdings Inc, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kossmann","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care Holdings Inc, Waltham, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2745-1429","authenticated-orcid":false,"given":"Len A.","family":"Usvyat","sequence":"additional","affiliation":[{"name":"Renal Research Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9546-4507","authenticated-orcid":false,"given":"Stefano","family":"Stuard","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care, Global Medical Office, Palazzo Pignano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"10","key":"B1-20260610","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","article-title":"The current and future landscape of dialysis","volume":"16","author":"Himmelfarb","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"6","key":"B2-20260610","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","article-title":"Epidemiology of haemodialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"B3-20260610","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2215\/CJN.03680411","article-title":"Early outcomes among those initiating chronic dialysis in the United States","volume":"6","author":"Chan","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B4-20260610","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000338673","article-title":"Patterns and predictors of early mortality in incident hemodialysis patients: new insights","volume":"35","author":"Lukowsky","year":"2012","journal-title":"Am J Nephrol."},{"issue":"4","key":"B5-20260610","doi-asserted-by":"crossref","first-page":"353-","DOI":"10.1001\/jamacardio.2019.0375","article-title":"Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US renal data system","volume":"4","author":"Modi","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B6-20260610","doi-asserted-by":"crossref","first-page":"104803","DOI":"10.1016\/j.healthpol.2023.104803","article-title":"The long-term effects of hospitalization on health care expenditures: an empirical analysis for the young-old population in Lombardy","volume":"132","author":"Torrini","year":"2023","journal-title":"Health Policy."},{"issue":"9","key":"B8-20260610","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/toxins15090531","article-title":"Unveiling the clinical benefits of high-volume hemodiafiltration: optimizing the removal of medium-weight uremic toxins and beyond","volume":"15","author":"Pedreros-Rosales","year":"2023","journal-title":"Toxins."},{"issue":"14","key":"B9-20260610","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.3390\/jcm14144860","article-title":"Why high-volume post-dilution hemodiafiltration should be the new standard in dialysis care: a comprehensive review of clinical outcomes and mechanisms","volume":"14","author":"Stuard","year":"2025","journal-title":"J Clin Med."},{"issue":"5","key":"B10-20260610","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.10110917","article-title":"Exploring the clinical relevance of providing increased removal of large middle molecules","volume":"13","author":"Wolley","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B11-20260610","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJMoa2304820","article-title":"CONVINCE Trial: effect of hemodiafiltration or hemodialysis on mortality in kidney failure","volume":"389","author":"Blankestijn","year":"2023","journal-title":"N Engl J Med."},{"issue":"12","key":"B12-20260610","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/ckj\/sfad258","article-title":"Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis?","volume":"16","author":"Mayne","year":"2023","journal-title":"Clin Kidney J."},{"issue":"2","key":"B13-20260610","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/bioengineering10020145","article-title":"Hemodiafiltration: technical and medical insights","volume":"10","author":"Lang","year":"2023","journal-title":"Bioengineering (Basel)."},{"issue":"3","key":"B14-20260610","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1681\/ASN.2012080875","article-title":"High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients","volume":"24","author":"Maduell","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B15-20260610","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/ndt\/gfv349","article-title":"Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials","volume":"31","author":"Peters","year":"2016","journal-title":"Nephrol Dial Transplant."},{"issue":"10464","key":"B16-20260610","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(24)01859-2","article-title":"Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials","volume":"404","author":"Vernooij","year":"2024","journal-title":"The Lancet."},{"issue":"1","key":"B17-20260610","doi-asserted-by":"crossref","first-page":"sfad247","DOI":"10.1093\/ckj\/sfad247","article-title":"Unmasking the CONVINCE trial: is hemodiafiltration ready to steal the spotlight in real-world practice?","volume":"17","author":"Meena","year":"2024","journal-title":"Clin Kidney J."},{"issue":"12","key":"B18-20260610","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1093\/ndt\/gfad136","article-title":"The EuDial Working Group of the European Renal Association. Haemodiafiltration for all: are we CONVINCEd?","volume":"38","author":"Shroff","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"suppl 4","key":"B19-20260610","first-page":"S94","article-title":"EuCliD (European Clinical Database): a database comparing different realities","volume":"14","author":"Marcelli","year":"2001","journal-title":"J Nephrol."},{"issue":"11","key":"B20-20260610","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/ckj\/sfad168","article-title":"From electronic health records to clinical management systems: how the digital transformation can support healthcare services","volume":"16","author":"Barbieri","year":"2023","journal-title":"Clin Kidney J."},{"issue":"1","key":"B21-20260610","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12882-016-0384-6","article-title":"Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study","volume":"17","author":"Assimon","year":"2016","journal-title":"BMC Nephrol."},{"issue":"1","key":"B22-20260610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12882-024-03934-y","article-title":"Real-world effectiveness of hemodialysis modalities: a retrospective cohort study","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Nephrol."},{"issue":"6","key":"B23-20260610","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1681\/ASN.2011121140","article-title":"Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes","volume":"23","author":"Grooteman","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B24-20260610","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ndt\/gfs407","article-title":"Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study","volume":"28","author":"Ok","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B25-20260610","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"Kalantar-Zadeh","year":"2009","journal-title":"Circulation."},{"issue":"4","key":"B26-20260610","doi-asserted-by":"crossref","first-page":"620-","DOI":"10.1093\/ndt\/gfw433","article-title":"Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the hypertension and the Kidney working group of the European Society of Hypertension (ESH)","volume":"32","author":"Sarafidis","year":"2017","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B27-20260610","doi-asserted-by":"crossref","first-page":"e001918","DOI":"10.1161\/JAHA.115.001918","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc."},{"issue":"4 suppl 1","key":"B28-20260610","article-title":"G-340 Applying real world experience of averted hospital admissions with high-volume HDF to reduced hospital costs to the US healthcare system","volume":"85","author":"Ficociello","year":"2025","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B29-20260610","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1523-1755.2002.00117.x","article-title":"Vascular access use in Europe and the United States: results from the DOPPS","volume":"61","author":"Pisoni","year":"2002","journal-title":"Kidney Int."},{"issue":"2","key":"B30-20260610","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2020.06.020","article-title":"International comparisons of native arteriovenous fistula patency and time to becoming catheter-free: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"77","author":"Pisoni","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B31-20260610","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.ki.5000186","article-title":"Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS","volume":"69","author":"Saran","year":"2006","journal-title":"Kidney Int."},{"issue":"3","key":"B32-20260610","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.ajkd.2011.04.021","article-title":"International differences in hemodialysis delivery and their influence on outcomes","volume":"58","author":"Kerr","year":"2011","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B33-20260610","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ckj\/sfw140","article-title":"Achieving high convection volumes in postdilution online hemodiafiltration: a prospective multicenter study","volume":"10","author":"de Roij van Zuijdewijn","year":"2017","journal-title":"Clin Kidney J."},{"issue":"7","key":"B34-20260610","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/toxins16070298","article-title":"Residual kidney function in hemodialysis: its importance and contribution to improved patient outcomes","volume":"16","author":"Obi","year":"2024","journal-title":"Toxins (Basel)."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:37:07Z","timestamp":1786369027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000955"}},"subtitle":["A Retrospective, International Cohort Study"],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000955","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2025-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}